Objective Trends in diabetes and cardiovascular mortality rates are considerably different between women and men; this can be partially explained by differences in diabetes control. The aim of this cross-sectional study was to assess whether sex differences exist in effective control of cardiovascular risk factors among persons with type 2 diabetes treated at the Vuk Vrhovac University Clinic in 2008.
Introduction
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both (1), and type 2 DM results from a progressive insulin secretory defect on the background of insulin resistance as opposed to type 1 DM which results from β-cell destruction, usually leading to absolute insulin deficiency (2) . Diabetes mellitus continues to increase in numbers and significance, thus becoming a growing burden in public health (3) . It is estimated that there are 235 million people with diabetes in 2010 (6.4% of the world population) and this number is expected to increase to 438 million by 2030 (7.7%) (4) . The number of persons with glucose intolerance worldwide is estimated to be 344 million in 2010 and is expected to rise to 472 million by 2030 (8.4% of adult population) (5) . The prevalence of DM in Croatia is 6.1% in the 18-65 age group (6) , with total prevalence in the age group 18+ estimated to be around 9% (5) .
The burden of risk factors for cardiovascular disease (CVD) in persons with diabetes is high, with 75% of diabetic patients suffering from hypertension and 64% from high cholesterol (7) . The relative risk of fatal coronary heart disease (CHD) associated with diabetes is 50% higher in women (8) . During the past 30 years, there has been a decline in both total and CVD-related mortality among men and women without diabetes (9) . Furthermore, a decline has also been observed in men with diabetes, while their female counterparts did not show this decline, with study of independent samples of U.S. population aged 35-74 from the National Health and Nutrition Surveys showing that in men with diabetes CVD mortality rates decreased from 26.4/ 1,000 person-years in 1971-1986 period to 12.8/1,000 person-years in 1988-2000, while in women with diabetes the CVD mortality rate did not decline between 1971-1986 (10.5/1,000 person-years) and 1988-2000 (9.4/1,000 personyears) (9, 10) . While the mortality rates of persons with DM are still higher in men, the difference is now much smaller than it was a few decades ago.
This sex difference in mortality trends in patients with diabetes has been attributed to physiological, biological (11) and behavioral (12) sex-based differences but may also be attributed to differences in the treatment of CVD risk factors (13) . Disparities in quality and accessibility of medical care (14, 15) are a further disadvantage of diabetic women, with insufficient data on these matters in Croatia and similar countries. An inappropriate regulation and treatment of cardiovascular disease risk factors may increase complications and mortality among patients. It has been shown that women are less aggressively treated for many CHD factors (8) and are more likely to have poorer control of HbA1c, systolic blood pressure as well as LDL cholesterol (16, 17) . In a recent study conducted on the US population women were also less likely than men to have HbA1c <7% (13) , which is an established risk factor for the development of diabetic complications (18) .
In Croatia, according to official mortality statistics for 2008, diseases of the circulatory system (International Classification of Diseases 10, codes I00-I99) were the main cause of death in 57.2% of Croatian women (crude mortality rate 644/100,000), as opposed to 43.5% of Croatian men (crude mortality rate 534/100,000) (19) . Furthermore, proportional diabetes mortality rates have constantly been higher in women than in men, with death certificate data from 2008 pointing to diabetes as an underlying cause of death in 2.92% of women (crude mortality rate 32.9/ 100,000) and 2.05% of men (crude mortality rate 25.2/ 100,000) (19) .
Since the majority of persons with diabetes are dying of cardiovascular causes, associated with macrovascular complications of diabetes, the sex inequalities in cardiovascular and diabetes mortality in Croatia could be, at least in part, explained by the differences in quality of diabetes care, including the control of blood pressure and serum cholesterol.
Therefore, the aim of this study was to investigate the differences in reaching the treatment goals in men and women with diabetes according to the existing guidelines in order to identify fields of possible improvement of diabetes care.
Materials and Methods
This study is a cross-sectional trial with data on patients with type 2 diabetes attending the Outpatient Department of Vuk Vrhovac University Clinic from January 1st to December 31st, 2008. The Outpatient Department of the Clinic annually covers around 20,000 patients from the area of Zagreb, the capital of Croatia.
Diabetologists at the Clinic use CroDiabNET (20), a software developed to assist with patient examination and data collection for the Croatian National Diabetes Registry. Laboratory parameters and data on diabetes complications, education, and therapy are entered in CroDiabNET in a way that constitutes a basic informatic sheet (BIS), recognized by the international diabetology community as the optimal data collection form for the follow-up and improvement of diabetes care (21) . The approval for usage and analysis of depersonalized data was obtained from Croatian Diabetes Registry.
In 2008 there were 16,984 patients with diagnosed diabetes and at least one visit to the Vuk Vrhovac University Clinic Outpatient Department. Of these patients, 15,311 were type 2 diabetics as defined by the attending diabetologist according to the criteria of World Health Organization (1), and 8,775 (57%) had all study endpoints measured at least once during the study period: HbA1c, systolic and diastolic blood pressures and blood lipids, with data on age, sex, body mass index and duration of diabetes available. The studied group (n=8,775) was compared by sex and age to the group of type 2 diabetics that did not have all of the study parameters present and was excluded from the study. The sex distribution did not differ significantly (p=0.271, chi-square), while the patients in our study group were older than those excluded from the study (63.83 ± 10.28 vs. 61.31 ± 13.69; p<0.001). For the purpose of this study, if more than one visit was recorded, the latest recorded data in 2008 on each parameter were taken.
To investigate whether there were any differences in the studied cardiovascular risk factors between female and male patients, the mean values of these parameters were compared according to sex. In addition, data were analyzed to establish the proportion of women and men who reached recommended target values of these risk factors, as defined by The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) (22) (SBP <130 mmHg, DBP <80 mmHg, LDL < 2.5 mmol/L, TG<1.7 mmol/L) and American Diabetes Association (23) (HbA1c <7%).
Prescribed diabetes therapy was defined as diet only, oral hypoglycemic agents (OHA), a combination of insulin+ OHA and insulin only.
Statistical analyses
Sex differences between levels of CVD risk factors were analyzed using Student's t-test. We used logistic regression models to estimate differences in the levels of CVD risk factors, with patient sex as an explanatory variable. The models were adjusted for age, duration of diabetes and BMI. Statistical significance was defined as p<0.05. All statistical analyses were performed using SAS (version 9.1.3).
Results
Subject characteristics are shown in Table 1 . Approximately 56% of patients had good glycemic control (HbA1c< 7.0%). Triglyceride levels were in control in 53%, while LDL levels were good in 36% of patients. Recommended levels of systolic and diastolic blood pressure were achieved in 18% and 14% of cases, respectively. More men than women were treated with OHA (54% vs. 48%), while women were more likely to be treated with insulin+OHA combination (23% vs. 18%) and insulin alone (28% vs. 26%).
Female persons with diabetes were found to have significantly higher levels of HbA1c, systolic blood pressure and LDL-cholesterol, while male patients had higher triglyceride levels. No sex differences were observed in diastolic blood pressure. Women were also found to be older, with longer diabetes duration and higher BMI. A significantly higher proportion of women did not reach recommended target levels of HbA1c, SBP and LDL in comparison with men, while there were no sex differences in the proportion of patients reaching target levels of DBP and TG.
In the unadjusted logistic regression model, women were more likely than men to have HbA1c !7.0%, systolic blood pressure !130 mmHg and LDL-cholesterol !2.5 mmol/L. The largest odds ratios between women and men were observed regarding systolic blood pressure control. The association of diastolic blood pressure and triglyceride levels with the patients' sex was not statistically significant. However, after adjusting for possible confounders (age, duration of diabetes and BMI) the odds ratio for women to have increased systolic blood pressure has somewhat decreased (OR=1.21; 95% CI 1.07-1.37) to a level similar to that for HbA1c (OR=1.21; 95% CI=1.11-1.32). Unadjusted and adjusted odds ratios are shown in Table 2 .
In addition to multivariate analysis, we categorized the patients by age and compared the levels of cardiovascular risk factors by sex (Table 3) . The results showed improvement in the levels of CVD risk factors with age (except for systolic blood pressure), and the sex differences were similar to those in the multivariate analysis.
Discussion
In this sample of persons with type 2 diabetes from the hospital outpatient department, the overall percentage of patients reaching target levels of HbA1c was comparable to that from other studies (24) (25) (26) . Women, however, had significantly higher mean values of HbA1c than men, reaching target levels (<7%) to a lesser extent, in spite of the more intense therapy for diabetes. This could be associated with longer diabetes duration, higher age and BMI observed in women.
While as much as over a half of the study population reached recommended targets for diabetes treatment, only 18% and 14% of patients reached the recommended levels of systolic and diastolic blood pressure, respectively. This is consistent with the previous research, showing that among patients with diabetes, physicians tend to focus more on antihyperglycemic treatment, although lipid and blood pressure control might be more effective in preventing patient-related endpoints (27) . The prevalence of hypertension is already reported to be greater in diabetic women than in diabetic men (28, 29) , and the women in the present study also had higher mean systolic blood pressure and reached target values less frequently. Although the present study was in agreement with a previous investigation reporting that women were more likely to have poor control of LDL-cholesterol levels as compared to men (30) , women were found to be at an even higher risk for poor SBP and HbA1c control. Literature shows that postmenopausal women have higher levels of LDLcholesterol, even after adjusting for age in comparison to premenopausal women (31) , and this increase is especially significant in perimenopause (32) ; however, the goals of treating LDL-cholesterol levels are the same in men and women. While we did not have data on menopausal status, the analysis stratified by age groups revealed that the age group 65+ had higher levels of LDL than the 45-64 age group (p<0.001; Scheffe's post hoc) and 20-44 age group (p<0.001), while the two younger groups had similar levels of LDL-cholesterol (p=0.192). It seems that the elderly diabetic women had more favourable lipid profiles, however without the data on statin therapy we cannot make further judgments on this issue. Interestingly, mean triglyceride levels were higher in men, while a similar proportion of males and females reached recommended target levels. It may be explained by the fact that a larger percentage of men have more significantly uncontrolled levels of TG (!4 mmol/L; 7.6% vs. 5.4%; p<0.001).
Previous research has shown that in patients with diabetes clinicians focus on antihyperglycemic treatment (7). Although achieving optimal blood glucose regulation is an important treatment goal, especially for the prevention of microvascular complications of diabetes, such an approach, may, given the limited time and human resources, lead to insufficient control and treatment of other CVD risk factors like blood pressure or serum cholesterol. Future research should be undertaken to clarify whether or not clinicians have different ways of reasoning in terms of CVD risk factors in diabetic men and women.
This study has several limitations -data on hypertension and dyslipidemia therapy were not available, which made estimates of the proportion of patients treated for these disorders impossible. Secondly, data on patients' smoking status, a known cardiovascular risk factor, were also not included because of their low availability. The strengths of this study are in its size, larger than most of the studies published in this field, and in the fact that this was the first research set to explore possible differences in CVD risk factors between women and men with diabetes in Croatia.
In conclusion, our data implicate that diabetic women have poorer control of the main potentially modifiable CVD risk factors than diabetic men. Since the current guidelines for CVD risk factors do not differentiate between men and women, efforts should be made to reach therapeutic targets in women and men alike. Moreover, diabetes control in women is worse despite the more intensified drug therapy, calling for greater inclusion of other types of treatment such as physical activity, education and psychological counselling. Further prospective research is needed to clarify the importance of CVD risk factor control in diabetic women and the differences in trends in overall and cardiovascular mortality in men and women with diabetes.
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